ClinicalTrials.Veeva

Menu

An End-to-end System for Assessment and Intervention of Frailty (SAIF)

T

Tan Tock Seng Hospital

Status

Completed

Conditions

Frailty

Treatments

Other: SAIF

Study type

Interventional

Funder types

Other

Identifiers

NCT05371210
2020/01163

Details and patient eligibility

About

The study aims to evaluate the feasibility and effectiveness of using SAIF (an end-to-end System for Assessment and Intervention of Frailty) to reduce the risk and delay the progress of physical frailty.

Full description

SAIF is a personalised, community-based system for both assessment and intervention of frailty. It comprises of 8 modules categorised into

  1. Interface: virtual nurse and caregiver gateway
  2. Assessment: computerised screening using Fried Frailty Phenotype (FFP) and FRAIL instruments, Gamified Walking While Talking to assess frailty status and predictive analytics to predict participant's frailty risk
  3. Intervention: Physical exercise kiosks (Cycling and Taichi) incorporated with games, polypharmacy management and nutrition recommendation

A total of 105 eligible community-dwelling older adults were recruited and randomised either to control arm or intervention arm using a single-consent Zelen's design. Allocation concealment was achieved using permutated block randomisation; both research assistant and participant were blinded to randomisation list during enrolment.

All participants completed baseline assessment and subsequent follow-up assessments (2-month, 4-month and 7-month). Additionally, participants in the intervention arm began SAIF interaction for a period of 4 months upon completion of their baseline assessment.

Enrollment

105 patients

Sex

All

Ages

60 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Age 60 and above
  2. CFS 4 or 5 / CFS 3 with FRAIL score at least 1 / CFS 3 with FPQ score at least 1
  3. Ambulate for at least 10m without walking aid
  4. English and/or Mandarin speaking

Exclusion criteria

  1. Known diagnosis of dementia or CMMSE score <19
  2. Parkinson's disease
  3. Hip surgery within the last 6 months
  4. Presence of end-stage organ failure, symptomatic heart conditions or COPD
  5. Active arthritis
  6. Hospitalisation within the last 1 month
  7. Participants who are unable to provide consent

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

105 participants in 2 patient groups

SAIF
Experimental group
Description:
After completion of baseline assessment, participants were required to interact with the SAIF system for 4 months. They were followed up at 2-month (mid-way of intervention), 4-month (end of intervention), and 7-month (3 months post-intervention).
Treatment:
Other: SAIF
Control
No Intervention group
Description:
Participants received a one-time health pamphlet after completing baseline assessment. They were followed up at 2-month, 4-month and 7-month thereafter.

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems